Christine Borowski - 29 Dec 2023 Form 3 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
Director
Signature
/s/ Mutya Harsch, Attorney-in-Fact for Christine Borowski
Issuer symbol
VYNE
Transactions as of
29 Dec 2023
Net transactions value
$0
Form type
3
Filing time
03 Jan 2024, 17:01:48 UTC
Next filing
03 Jan 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24.1 - Power of Attorney